{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:11:49Z","timestamp":1777392709920,"version":"3.51.4"},"reference-count":12,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            To clarify the relationship between mutations commonly found for penicillin-binding protein 3 (PBP 3) of \u03b2-lactamase-nonproducing ampicillin-resistant (BLNAR)\n            <jats:italic>Haemophilus influenzae<\/jats:italic>\n            isolates and \u03b2-lactam resistance, single and multiple amino acid mutations at positions 377, 385, 389, 517, and 526 were introduced into PBP 3 of a \u03b2-lactam-susceptible Rd strain by site-directed mutagenesis. Twelve isogenic recombinant strains were challenged with nine \u03b2-lactam antibiotics. Replacement of the asparagine at position 526 with lysine (N526K) increased the resistance to imipenem eightfold and increased the resistance to various cephalosporins two- to eightfold. Substitution of threonine for serine at position 385 (S385T) and\/or substitution of phenylalanine for leucine at position 389 (L389F), in addition to the N526K mutation, led to two- to fourfold additional increases in cephalosporin resistance. An isoleucine-to-methionine substitution at position 377 did not change the antibiotic sensitivity of any of the recombinant strains also carrying other PBP 3 mutations tested. Thirty-six clinical isolates carrying a PBP 3 gene (\n            <jats:italic>ftsI<\/jats:italic>\n            ) with the S385T, L389F, R517H, and\/or N526K mutation were chosen from among 279 clinical isolates collected in Japan, and the isolates were grouped into six classes on the basis of the patterns of the four mutations in PBP 3. Rd recombinants were made with each of the\n            <jats:italic>ftsI<\/jats:italic>\n            genes. The levels of resistance to \u03b2-lactams varied between recombinants of different classes but were comparable for those of the same class. The levels of resistance to cephalosporins of these recombinants were similar to those of the parent clinical isolates, while those to ampicillin and carbapenems were lower. These results indicate that resistance to \u03b2-lactams, at least to cephalosporins, depends in large part on the PBP 3 mutations R517H, N526K, S385T, and L389F.\n          <\/jats:p>","DOI":"10.1128\/aac.49.7.2834-2839.2005","type":"journal-article","created":{"date-parts":[[2005,6,25]],"date-time":"2005-06-25T02:22:50Z","timestamp":1119666170000},"page":"2834-2839","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":63,"title":["Genetic Approach To Study the Relationship between Penicillin-Binding Protein 3 Mutations and\n            <i>Haemophilus influenzae<\/i>\n            \u03b2-Lactam Resistance by Using Site-Directed Mutagenesis and Gene Recombinants"],"prefix":"10.1128","volume":"49","author":[{"given":"Yumi","family":"Osaki","sequence":"first","affiliation":[{"name":"Pharmaceutical Research Department, Meiji Seika Kaisha Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama 222-8567, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Sanbongi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Department, Meiji Seika Kaisha Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama 222-8567, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Department, Meiji Seika Kaisha Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama 222-8567, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Department, Meiji Seika Kaisha Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama 222-8567, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Department, Meiji Seika Kaisha Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama 222-8567, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Maeda","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Department, Meiji Seika Kaisha Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama 222-8567, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ida","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Department, Meiji Seika Kaisha Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama 222-8567, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.7.2208-2218.2002"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/107662903764736337"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1630-1639.2004"},{"key":"e_1_3_2_5_2","first-page":"369","volume":"49","year":"2001","unstructured":"Konno, M., K. Ubukata, N. Chiba, K. Hasegawa, Y. Shibasaki, K. Sudo, K. Kishibe, H. Hujikawa, M. Sakai, Y. Koyama, M. Yokota, and T. Mayama. 2001. Postmarketing special investigation and its verification of precision for cefditoren pivoxil. Jpn. J. Chemother.49:369-396. (In Japanese.)","journal-title":"Jpn. J. Chemother."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg474"},{"key":"e_1_3_2_7_2","unstructured":"National Committee for Clinical Laboratory Standards. 2002. Methods for dilution antimicrobial susceptibility for bacteria that grow aerobically; approved standard 5th ed. NCCLS document M7-A5 vol. 20 no. 2. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.7.1678"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg107"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-002-0209-3"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-003-0278-Y"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1693-1699.2001"},{"key":"e_1_3_2_13_2","first-page":"209","volume":"51","year":"2003","unstructured":"Yoshida, I., G. Sugimori, I. Higashiyama, Y. Kimura, and Y. Yamano. 2003. Surveillance of susceptibility of clinical isolates of various bacterial species to antibacterial agents. Jpn. J. Chemother.51:209-232. (In Japanese.)","journal-title":"Jpn. J. Chemother."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.7.2834-2839.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.7.2834-2839.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T19:11:14Z","timestamp":1645470674000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.49.7.2834-2839.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1128\/AAC.49.7.2834-2839.2005"],"URL":"https:\/\/doi.org\/10.1128\/aac.49.7.2834-2839.2005","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"2004-08-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-03-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}